| Mechanism of Action | Antiviral | % Correct |
|---|---|---|
| DNA Chain Teminators | Acyclovir | 83%
|
| DNA Chain Teminators | Valacyclovir | 67%
|
| DNA Chain Teminators | Ganciclovir | 58%
|
| Neuramidase inhibitors | Oseltamivir | 58%
|
| Protease Inhibitors (HIV) | Ritonavir | 50%
|
| PK Enhancers | Ritonavir | 50%
|
| NNRTIs | Efavirenz | 42%
|
| NRTIs | Emtricitabine | 42%
|
| DNA Chain Teminators | Valganciclovir | 42%
|
| NRTIs | Zidovudine | 33%
|
| DNA Chain Teminators | Cidofovir | 25%
|
| INSTIs | Dolutegravir | 25%
|
| Entry Inhibitors | Enfuvirtide | 25%
|
| DNA Chain Teminators | Foscarnet | 25%
|
| Adamantanes | Amantadine | 17%
|
| Protease Inhibitors (HIV) | Darunavir | 17%
|
| NRTIs | Didanosine | 17%
|
| NRTIs | Entecavir | 17%
|
| INSTIs | Raltegravir | 17%
|
| Viral Polymerase Inhibitor | Remdesivir | 17%
|
| Others | Ribavirin | 17%
|
| NRTIs | Abacavir | 8%
|
| NRTIs | Adefovir | 8%
|
| Protease Inhibitors (HIV) | Atazanavir | 8%
|
| INSTIs | Cabotegravir | 8%
|
| PK Enhancers | Cobicistat | 8%
|
| NNRTIs | Doravirine | 8%
|
| NS5As | Elbasvir | 8%
|
| DNA Chain Teminators | Famciclovir | 8%
|
| Protease Inhibitors (HCV) | Glecaprevir | 8%
|
| Protease Inhibitors (HCV) | Grazoprevir | 8%
|
| Protease Inhibitors (HIV) | Indinavir | 8%
|
| NRTIs | Lamivudine | 8%
|
| Protease Inhibitors (HIV) | Lopinavir | 8%
|
| Entry Inhibitors | Maraviroc | 8%
|
| NNRTIs | Nevirapine | 8%
|
| NS5As | Pibrentasvir | 8%
|
| NNRTIs | Rilpivirine | 8%
|
| Adamantanes | Rimantadine | 8%
|
| Endonuclease Inhibitor | Baloxavir marboxil | 0%
|
| INSTIs | Bictegarvil | 0%
|
| Protease Inhibitors (HCV) | Bocepravir | 0%
|
| DNA Chain Teminators | Brincidofovir | 0%
|
| NS5As | Daclatasvir | 0%
|
| NS5Bs | Dasabuvir | 0%
|
| NNRTIs | Delaviridine | 0%
|
| INSTIs | Elvitegravir | 0%
|
| NNRTIs | Etraviridine | 0%
|
| Protease Inhibitors (HIV) | Fosamprenavir | 0%
|
| Entry Inhibitors | Fostemsavir | 0%
|
| Others | Imiquimod | 0%
|
| Others | Interferon | 0%
|
| NS5As | Ledipasvir | 0%
|
| Others | Letermovir | 0%
|
| NS5As | Ombitazvir | 0%
|
| Entry Inhibitors | Palivizumab | 0%
|
| Protease Inhibitors (HCV) | Paritaprevir | 0%
|
| Others | Peginterferon | 0%
|
| DNA Chain Teminators | Penciclovir | 0%
|
| Neuramidase inhibitors | Peramavir | 0%
|
| Protease Inhibitors (HCV) | Simeprevir | 0%
|
| NS5Bs | Sofsbuvir | 0%
|
| NRTIs | Stavudine | 0%
|
| Others | Tecovirimet | 0%
|
| Protease Inhibitors (HCV) | Telapravir | 0%
|
| NRTIs | Tenofovir alafenamide|TAF | 0%
|
| NRTIs | Tenofovir disoproxil fumarate|TDF | 0%
|
| NS5As | Velpatasvir | 0%
|
| Protease Inhibitors (HCV) | Voxilaprevir | 0%
|
| Neuramidase inhibitors | Zanamavir | 0%
|